Tag Archives: disease

Heart disease is number one killer among women

Heart disease is number one killer among women
KUALA LUMPUR: Heart disease is the number one killer among Malaysian women and is two and a half times as common than dying from all cancers combined, warned the National Heart Association of Malaysia. Its president Datuk Dr Azhari Rosman
Read more on The Star Online

Third Rock Ventures invests M to form heart disease co. MyoKardia
Boston-based Third Rock Ventures today announced the formation of MyoKardia Inc. with a $ 38 million Series A financing of the company. MyoKardia, which will be located in San Francisco and is the second company launched out of Third Rock's West
Read more on Boston Herald

Latest Cardiovascular Disease News

Low-carb, high-protein diet 'heart risk'
They found that proportional decreases in carbohydrate intake and increases in protein intake were associated with a small increase in the risk of cardiovascular disease such as heart attack and stroke. This sort of study can provide useful estimates
Read more on Ripon Today

Most Psoriasis Patients at Risk for Heart Disease
ORLANDO – A recent study that found a high prevalence of undiagnosed or untreated cardiovascular risk factors among patients with moderate to severe psoriasis reinforces the need for routine screening, said Dr. Jeffrey P. Callen. Cardiovascular disease
Read more on Family Practice News Digital Network

The New Science Behind America's Deadliest Diseases
What do heart disease, diabetes, Alzheimer's, stroke and cancer have in common? Scientists have linked each of these to a condition known as chronic inflammation, and they are studying how high-fat foods and excess body weight may increase the risk for
Read more on Wall Street Journal (blog)

Sexual Dysfunction May Be A Tip-off To Heart Disease In Diabetic Men

Sexual Dysfunction May Be A Tip-off To Heart Disease In Diabetic Men
Osteochondritis Dissecans, Osteomyelitis (Bone Infection), Osteopathy, Osteoporosis, Otitis Externa (Swimmer's Ear), Ovarian Cancer, Ovarian Cyst, Paget's Disease (Of Bone), Pain, Painful Intercourse (Dyspareunia), Pancreatic Cancer, Pancreatitis
Read more on Medical News Today

Cyberbullying: One In Two Victims Suffer From The Distribution Of Embarrassing
Pneumococcal disease is an infection caused by the Streptococcus pneumoniae (S. pneumoniae) bacterium, also known as pneumococcus. Infection can result in pneumonia, infection of the blood (bacteremia/sepsis), middle-ear infection (otitis media).
Read more on Medical News Today

New State-of-the-Art Institute for Digestive Health and Liver Disease Opens at Mercy Medical Center


Baltimore, MD (Vocus) September 15, 2008

Mercy Medical Center will open the doors of its new, multi-million dollar, one-of-a-kind treatment center for the diagnosis and treatment of digestive diseases on Monday, Sept. 15, 2008. The Institute for Digestive Health and Liver Disease at Mercy comprises the entire 7th floor of Mercy’s Professional Office Building.

The Institute will address inflammatory bowel disease, hepatology, gastroenterology, endoscopy, colon-rectal disorders, and provide Remicade infusion services, Thomas R. Mullen, President and CEO of Mercy Health Services, Mercy Medical Center, has announced.

Joining Mercy are renowned physicians Drs. Paul Thuluvath, Mary Harris, and Sergey Kantsevoy – all formerly of Johns Hopkins. They join the noted Mercy team of gastroenterologists, Drs. David Posner, Michael Cox, Scott Huber and Patrick Hyatt, and colon-rectal surgeon, Dr. Debra Vachon.

In addition, gastroenterologists Drs. Richard Desi and Laura Pichney will also be members of the new team, bringing expertise in community colorectal screening.

“By combining the medical expertise of these physicians with progressive technology -

including state-of-the-art endoscopic equipment, as well as Mercy’s 134-tradition of providing compassionate and quality care – the new Institute for Digestive Health and Liver Disease at Mercy is positioned to be the leading center in the region for digestive health,” Mr. Mullen said.

According to Mercy Chief of Gastroenterology Dr. David Posner, Director of the new Institute, patients will have access to endoscopic procedures such as interventional endoscopy, endoscopic ultrasound and capsule endoscopy for the diagnosis of “a number of digestive and related disorders. The Institute provides expert treatment for bilary tract disease including bile duct cancer; gallstone disease, inflammatory conditions of the colon, Crohn’s Disease, ulcerative colitis, inflammatory bowel and irritable bowel disease, colorectal cancer, esophageal disorders, reflux, swallowing disorders, heartburn, liver disease including hepatitis, and as well as disorders of the pancreas, stomach and duodenum,” Dr. Posner said.

The new Institute will also take part in clinical trials for Hepatitis B, C, and liver cancer, as well as genetic counseling and preventive medical services, in coordination with Mercy’s Prevention and Research center under nationally renowned cancer researcher and epidemiologist Dr. Kathy J. Helzlsouer.

Other features to the Institute will include a women’s center for diarrheal management, treating inflammatory bowel disease in pregnancy, minimally invasive endoscopic surgery, a comprehensive liver center, including liver transplantation services, and a Remicade infusion center.

Remicade (Infliximba) is a drug used to treat autoimmune disorders and has been approved by the USFDA for the treatment of Crohn’s Disease and ulcerative colitis. Remicade is delivered by intravenous infusion or IV, typically at 6-8 week intervals.

“Many of the physicians who comprise the staff of the new Institute have national and international reputations for their work, such as in the treatment of inflammatory bowel disease, chronic liver disease, pancreatic cancer, and more. Mercy already has a reputation as one of the nation’s finest hospitals in terms of quality of care. This new Institute is further evidence of our dedication to providing patients with advanced therapies so that they may enjoy a better, healthier, quality of life,” Mr. Mullen said.

Below are brief biographies of the new Institute’s physician staff:

David B. Posner, M.D.

David B. Posner, M.D., Chief of Gastroenterology at Mercy, is a graduate of the University of Maryland School of Medicine. Dr. Posner is certified by the American Board of Internal Medicine with a subspecialty in Gastroenterology. He is a fellow of the American College of Physicians, American Gastroenterological Society, and American College of Gastroenterology as well as American Society for Gastrointestinal Endoscopy, American Association for the Study of Liver Diseases, and Baltimore City Medical Society. Dr. Posner is past president of the Maryland Society of Gastrointestinal Endoscopy.

For the past 20 years, Dr. Posner has taught students and residents from the University of Maryland. As Attending Physician at Mercy Medical Center, Dr. Posner teaches residents in medicine and surgery and received the Outstanding Physician-Teacher Award in 1982. He has authored numerous abstracts and publications.

Paul J. Thuluvath, M.D.

Paul J. Thuluvath, M.D., received his medical degree from the University of Sheffield School of Medicine, England. He completed an internship and residency in Internal Medicine at St. Johns Medical College Hospital, India, as well as a residency in Internal Medicine at the Dunston Hill Hospital and Castle Hill Hospital, England. He completed his Gastroenterology and Hepatology fellowship at the University of Cambridge, England. Board Certified in Gastroenterology and Internal Medicine, Dr. Thuluvath specializes in liver disease, liver transplantation, ERCP, liver cancer, and primary sclerosing cholangitis. He has extensive research experience, has authored numerous articles, book chapters, and editorials, and is an international speaker. A fellow of the American College of Gastroenterology and Royal College of Physicians of London, Dr. Thuluvath is a member of the American Association for Study of Liver Disease, American Gastrenterological Association, American Society for Gastrointestinal Endoscopy, International Liver Transplant Society, The Transplantation Society, and European Association for Study of Liver Diseases.

Mary L. Harris, M.D.

Mary L. Harris, M.D., received her medical degree from the University of Virginia School of Medicine, where she also completed her internship and residency in Internal Medicine. She completed her Gastroenterology fellowship at The Johns Hopkins Hospital. Her interests include Crohn’s Disease, ulcerative colitis, pregnancy and IBD, general endoscopy, and diarrhea. Dr. Harris is a member of the American Gastroenterologist Association and American College of Physicians. She also serves on the Board of Directors of the Maryland Crohn’s & Colitis Foundation of America Physician Advisory Committee. Dr. Harris has participated in many research programs and is the author of many manuscripts, book chapters, and abstracts.

Sergey Kantsevoy, M.D., Ph.D.

Sergey Kantsevoy, M.D., Ph.D., received his medical degree from Gorky Medical Institute, Gorky, Russia, where he also completed a residency in Surgery. His surgical internship was completed at Bronx-Lebanon Hospital Center, Bronx, NY. He completed an Internal Medicine internship and residency at Washington Hospital Center, Washington, D.C. Dr. Kantsevoy completed his fellowship in Gastroenterology and Hepatology at The Johns Hopkins University School of Medicine. Board Certified in Gastroenterology and Hepatology as well as Internal Medicine, Dr. Kantsevoy specializes in interventional endoscopy and endoscopic ultrasound. He is a member of the American Gastroenterological Association and American Society for Gastrointestinal Endoscopy. Dr. Kantsevoy is an international lecturer and course director, author of various abstracts, book chapters, and articles, and has been issued various patents.

Michael E. Cox, M.D.

Michael E. Cox, M.D., Assistant Chief of Gastroenterology, is a graduate of the University of Maryland Medical School with certifications in both Gastroenterology and Internal Medicine. His research interests include endoscopic laser surgery and Hepatitis C. He has been a clinical assistant professor of medicine at the University of Maryland since 1981 and was the first medical director of the Maryland Endoscopy Center. Dr. Cox is a member of the American Gastroenterology Association and American Society of Gastrointestinal Endoscopy, as well as Maryland Society of Gastrointestinal Endoscopy, for which he served as president from 1997 through 1999. His fellowships include the American College of Gastroenterology (FACG) and American College of Physicians (FACP). He has authored numerous papers and publications.

Debra A. Vachon, M.D.

Debra A. Vachon, M.D., received her medical degree from the University of Maryland School of Medicine. Board Certified in both general surgery and colon-rectal surgery, Dr. Vachon is a fellow of the American College of Surgeons and American Society of Colon and Rectal Surgeons. She has made numerous presentations regarding the Delorme procedure for complete rectal prolapse in severely debilitated patients; management of inflammatory carcinoma of the breast; and surgical complications in children with HIV infections

Scott Huber, M.D.

Scott Huber, M.D., earned his medical degree from the University of Pittsburgh School of Medicine. He completed his residency in Internal Medicine through the University of Maryland Medical System and fellowship in Gastroenterology at Brown University and Rhode Island Hospital. Board Certified in Internal Medicine and specialist in Gastroenterology, Dr. Huber has conducted research in the gastroenterology field at Brown University and Johns Hopkins University.

Patrick Hyatt, M.D.

Patrick Hyatt, M.D., earned his medical degree at the Temple University School of Medicine in Philadelphia. He completed his residency in Internal Medicine and his fellowship in Gastroenterology at Brown University in Providence, Rhode Island. Dr. Hyatt is certified by the American Board of Internal Medicine and is Board-Eligible in Gastroenterology. He has numerous clinical presentations and medical publications to his credit, addressing disorders of the GI tract as well as treatments such as chemoprevention of colon cancer. Dr. Hyatt is a member of the American Gastroenterological Association, American Society of Gastrointestinal Endoscopy, and American College of Gastroenterology.

Lisa Pichney, M.D.

Lisa Pichney, M.D., received her medical degree from the University of Maryland School of Medicine. She completed her internship and residency in Internal Medicine and her fellowship in Gastroenterology at the University of Maryland Hospital/Baltimore V.A. Medical Center. Board Certified in Gastroenterology and Internal Medicine, Dr. Pichney serves on the Board of Governors of the Maryland Endoscopy Center, is President of the Maryland Society for Gastrointestinal Endoscopy, and is a Physician Member of Crohn’s & Colitis Foundation of America. She is a member of various medical associations, including Med-Chi of Maryland, Phi Beta Kappa Honor Society, Alpha Omega Alpha Honor Medical Society, American Gastroenterological Association, American Society for Gastroenterological Endoscopy, American College of Physicians, and Baltimore County Medical Association. A fellow of the American College of Physicians/ASIM and American College of Gastroenterology, Dr. Pichney has been the recipient of numerous awards, is the author of various publications and abstracts, and has presented numerous lectures.

Richard A. Desi, M.D.

Richard A. Desi, M.D., received his medical degree from the University of Maryland School of Medicine and completed his residency at the University of Maryland Department of Internal Medicine. He completed his Gastroenterology fellowship at Georgetown University Hospital. Dr. Desi is Board Certified in Internal Medicine and is Board-Eligible in Gastroenterology. He is a member of the American Gastroenterological Association and American College of Gastroenterology.

The Institute for Digestive Health and Liver Disease at Mercy is located on the 7th floor of Mercy’s Professional Office Building at 301 St. Paul Street. Call 410-332-9829 or call

1-800-M.D.-Mercy for an appointment.

Mercy Medical Center is a 134-year-old, university affiliated medical facility named one of the top 100 hospitals in the nation and among 10 best centers for women’s health care. Mercy is home to the nationally acclaimed Weinberg Center for Women’s Health and Medicine, and in 2010, will open the new $ 400 million Mary Catherine Bunting Center for inpatient care. For more information, visit Mercy online at http://www.mdmercy.com or call 1-800-M.D.-Mercy.

Editor’s note: Caption for accompanying photo, Mercy Medical Center’s Institute for Digestive Health and Liver Disease features a highly skilled and talented staff of physicians (left to right, first row): David B. Posner, M.D., Paul J. Thuluvath, M.D., Mary L. Harris, M.D., Sergey Kantsevoy, M.D., Ph.D. (left to right, back row): Lisa Pichney, M.D., Michael E. Cox, M.D., Debra A. Vachon, M.D., Patrick Hyatt, M.D., Scott Huber, M.D., and Richard A. Desi, M.D.

###







Restoring a Classic Dodge Over Six Decades Forges a Lifeline for an Artist With Parkinson’s Disease.


Bellingham, WA (PRWEB) February 29, 2012

A man restoring life, glory, and spirit to an aging, abandoned automobile isn’t unusual. In “The Dodge: Guts, Glory, and Living at Full-Throttle,” though, it is almost mystical how one 1941 Dodge D-19 Luxury Liner convertible snagged Mike’s 17-year-old’s heart and is still in his life sixty years later, filling a remarkable role. They’ve both weathered life’s many passages — even the assaults on his quality of life and emerging disabilities from Parkinson’s disease; she, abandonment and deterioration when he goes off to war.

Award-winning potter and sculptor and lifelong auto collector and restoration enthusiast, Eduard Alden ?Mike? Mikkelsen, collaborated on this new memoir (February 2012) with his wife, Anne Cutter Mikkelsen. Anne, a French trained chef, Master Gardener, writer ? and carepartner to Mike ? also is the author of ?Take Charge of Parkinson?s Disease: Dynamic Lifestyle Changes to Put You in the Driver’s Seat,? which shares how the couple has learned to live vibrantly with PD since his 1993 diagnosis. Now, ?The Dodge? recounts the intertwined life stories of Mike, Anne, and the beloved automobile, which seems to come to life each time they need her most. Together, they share a valuable message about the loss of control underscoring PD and other neurodegenerative disease: Make the most of what we can control ? how we choose to think about our circumstances and what we bring to our relationships.

From the authors — who live in Bellingham, WA and have deep roots in Minnesota — about “The Dodge: Guts, Glory, and Living at Full-Throttle”:

It was love at first sight. Mike, a 17-year old Lewistown, Montana cowboy, wanted to own the 1941 Dodge D-19 Luxury Liner convertible. She sat, neglected and alone,with a prickly bale of hay on her backseat.????

Two years after driving the Dodge home to Montana, Mike had to leave her when he went to war. Eventually she found herself at the bottom of a Montana coulee. Twenty years passed, a tree grew through her body and wild flowers flowed from her glovebox. She almost gave up hope of ever seeing him again.

Meanwhile a silent invader was taking root inside Mike forcing him down into his own pit.

Set on forty acres outside Northfield, Minnesota, the car/man journey of renewal and rebirth folds Mike?s lifelong passion for cars into his wife, Anne?s love of food, plants and children. While Anne, a French-trained chef, provides peace and sustenance for guests at her country B&B, Mike, an artist of clay and metal, juggles a robust auto restoration business in the basement of the garage with a pottery and sculpture studio upstairs. Life at full-throttle.

As Parkinson?s disease threatens to alter the couple’s lifestyle, the Dodge comes to life adding a powerful ingredient to their Quality of Life recipe. This story of perseverance, love and commitment is not just a tale of restoring a beloved “rolling sculpture.” For Mike and the Dodge, the creation and evolution of their magical bond ultimately provides a life-line for both.

Read an excerpt from “The Dodge.”

About “Take Charge of Parkinson’s Disease”: The personal story of how she and Mike learned to live vibrantly since his 1993 PD diagnosis. Presents information on re-focused nutrition, exercise, and healthy emotional coping strategies that may play roles in maintaining optimal health while living with Parkinson’s disease and other neurodegenerative disorders like multiple sclerosis.

A French trained chef, Master Gardener, and a former restaurateur and bed and breakfast proprietor, Anne presents more than 80 of her own original recipes and menus that combine a wide variety of anti-oxidant, anti-inflammatory, nutrient-rich ingredients, and culinary herbs and spices known to favorably impact the brain.

“The Dodge: Guts, Glory, and Living at Full-Throttle”

By Anne Cutter Mikkelsen and Eduard Alden Mikkelsen

Non-fiction, 264 pages

Paperback ISBN 978-0-983198222; ebook ISBN 978-0-983198215

Willow Island Press (2012)

Available at http://www.annecuttermikkelsen.com and http://www.Amazon.com.

“Take Charge of Parkinson’s Disease: Dynamic Lifestye Changes to Put You in the Driver’s Seat”

Named to “Top 20″ List of Small Press Titles Most in Demand from Libraries and Bookstores (Library Journal, March 1, 2012).

By Anne Cutter Mikkelsen and Carolyn Stinson

ISBN 13: 978-0-9823219-3-5

A DiaMedica Publishing Guide to Optimum Wellness (2011)

Available at http://www.annecuttermikkelsen.com, http://www.Amazon.com and in Bookstores

###





More Parkinsons Press Releases

“Take Charge of Parkinson’s Disease” Named to Top 20 In Demand List by Libraries and Bookstores


Baltimore, Md (PRWEB) February 29, 2012

“Take Charge of Parkinson’s Disease: Dynamic Lifestyle Changes to Put You in the Driver’s Seat” has been named to the Top 20 List of Books in Demand Nationwide by Libraries and Bookstores from Quality Books in the March 1, 2012 Library Journal. Number four on the list, “Take Charge” is an unusual how-to book for boosting physical and emotional resilience through brain healthy nutrition, exercise, and enlightened caregiving. More than 80 original recipes with the widest variety of anti-oxidant, anti-inflammatory, nutrient-rich ingredients, and culinary herbs and spices known to favorably impact the brain are presented by author Anne Cutter Mikkelsen, a French trained chef, Master Gardener, and carepartner to her husband Eduard Alden “Mike” Mikkelsen, an award-winning sculptor and potter, who was diagnosed with PD in 1993.

The Library Journal’s Top 20 List published on March 1, 2012, covers the six months prior to the week ending February 18, 2012. Library Journal, LLC is a wholly-owned subsidiary of Media Source, Inc.

Anne’s and Mike’s own stirring personal story of transcending the disease and living vibrantly provides the context for information about re-focusing nurition, developing healthy emotional coping strategies, risk factors, and research that points to potential neuroprotective and symptom management benefits afforded by certain types of exercise. The couple wishes to help cut the learning curve for others facing down a Parkinson’s disease diagnosis. “Take Charge” espouses making the most of what we can control: what we eat, how we choose to think about our circumstances, and what we bring to our relationships.

Read praise, reviews and excerpts.

“Take Charge of Parkinson’s Disease: Dynamic Lifestye Changes to Put You in the Driver’s Seat”

Anne Cutter Mikkelsen and Carolyn Stinson

ISBN 13: 978-0-9823219-3-5

A DiaMedica Publishing Guide to Optimum Wellness

(2011)

Available in paperback and e-book from Amazon.com, Bookstores, and at http://www.annecuttermikkelsen.com.

###





Related Parkinsons Press Releases

MDS 15th International Congress of Parkinson’s Disease and Movement Disorders

TORONTO, ON, Can (PRWEB) May 31, 2011

The world?s leading experts in Parkinson?s disease and Movement Disorders will present the latest research findings and state-of-the-art treatment options at The Movement Disorder Society?s 15th International Congress of Parkinson?s Disease and Movement Disorders in Toronto, June 5-9, 2011.

The 15th International Congress, held at the Metro Toronto Convention Centre, will be attended by over 3,200 physicians, researchers and other healthcare professionals from 74 countries. Attendees will be able to view over 1,100 scientific abstracts submitted by clinicians from around the world. The International Congress Scientific Program consists of Plenary, Parallel, and Video Sessions, as well as Skills Workshops, Teaching Courses, and Guided Poster Tours.

Members of the media receive complimentary full-access registration to the Congress. For information on how to register, please view the MDS Press Information Web page. http://www.movementdisorders.org/congress/congress11/press.php

News Releases http://www.movementdisorders.org/congress/congress11/news_releases/

Read summaries of newsworthy research to be presented at the Congress.

Early dietary treatment of galactosemia is not enough to prevent development of movement disorders

Caffeine shown to influence age at onset in Huntington’s disease

Apathy is independent from depression and dementia in Parkinson’s disease

Inhaled apomorphine reduces “off” periods in Parkinson’s disease

Cycling ability maintained in Parkinson’s disease patients with freezing of gait

Polysomnographic findings in sleep disturbed Parkinson’s disease patients provide diagnostic and disease progression measurement tools

The LRRK2 G2019S mutation suggests Parkinson’s disease patients maybe predisposed to cancer

Safety and efficacy of octanoic acid in the treatment of essential tremor

15th International Congress Information

The International Congress section of the MDS website contains all the information you need to prepare for the meeting. http://www.movementdisorders.org/congress/congress11/

Final Program http://www.movementdisorders.org/congress/congress11/

MDS Press Policies, Press Room Information and Registration http://www.movementdisorders.org/congress/congress11/press.php

We look forward to seeing you in Toronto!

The Movement Disorder Society, an international society of over 3,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research. For more information about The Movement Disorder Society, visit http://www.movementdisorders.org.

Note: To receive additional materials or to register for the MDS 15th International Congress of Parkinson?s Disease and Movement Disorders, please contact Elizabeth Laur, elaur(at)movementdisorders(dot)org

###







More Early Onset Press Releases

Amyloid Beta Level in Serum Predicts Risk for Vascular Disease in First-Degree Relatives of Alzheimer?s Patients

Manhasset, NY (Vocus) February 6, 2009

People with a family history of Alzheimer?s disease, who have high levels of amyloid beta (A?) in the serum, are at increased risk for vascular disease. These heightened A? levels may predict whether those without symptoms may progress towards dementia in years to come.

Michael Mullan, MD, and his colleagues at the Roskamp Institute in Sarasota, Fl., collaborated with statisticians at the London School of Hygiene and Tropical Medicine to see if elevated levels of A? in the blood in first-degree relatives of Alzheimer?s patients are associated with risk factors for vascular disease. Recent studies have shown that vascular disease is a major risk factor for Alzheimer?s. They recruited 197 local study subjects from the Alzheimer?s Disease Anti-Inflammatory Prevention Trial, which included unaffected family members, as well as 98 community elders in Florida. They studied the association of amyloid beta levels in serum with risk factors for vascular disease, including total cholesterol, LDL, HDL, systolic blood pressure, diastolic blood pressure and serum creatinine. They also looked at medications prescribed for vascular disease or the risk factors associated with vascular disease.

A? in serum is used as a marker to predict A? accumulation in the brain, which is one of the key pathologies of Alzheimer?s. In this study, the scientists found A? levels were significantly higher in first-degree relatives of Alzheimer?s patients, as compared with the elder community controls. The scientists say they suspect this elevation may be ?indicative of increased amyloid beta production due to genetic and/or other risk factors.?

?These findings suggest that an increased risk of Alzheimer?s disease associated with family history may be mediated in part through the enrichment of individuals with vascular risk factors and may be reflective of pre-symptomatic Alzheimer?s disease pathology,? Dr. Mullan and his colleagues wrote.

In another stunning finding in the same issue of Molecular Medicine, scientists from Virginia Commonwealth University, Northwestern University, UCSF, UCLA, University of Pennsylvania, and University of North Carolina, identified a genetic signature for a hepatitis C virus-induced liver cancer, and different genetic handprints for cirrhosis caused by hepatitis C. They were able to use these genetic signatures to distinguish between pathological stages of liver cancer and early disease states, suggesting a way to diagnose this hepatocellular carcinoma earlier in the disease process.

Molecular Medicine is published by The Feinstein Institute for Medical Research, part of the North Shore-LIJ Health System. For more information on the study, visit http://www.molmed.org or contact Veronica J. Davis. Free podcasts from the latest issue of Molecular Medicine are also available on the journal?s web site and in iTunes.

###







Related Carcinoma Press Releases

New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines


New York, NY (PRWEB) June 19, 2012

A new syndicated TrendsmemeTM Report: Immune and Inflammatory Diseases has been released by Medmeme, LLC., a global leader in comprehensive, integrated medical and science information database platforms. The report details the trends and potential for drug developers in immune/inflammatory diseases particularly focusing on three key disease indications: RA (rheumatoid arthritis), IBD (inflammatory bowel disease), and SLE (systemic lupus erythematosus). According to the Centers for Disease Control and Prevention (CDC) and the Arthritis Foundation (AF), between 1.3 million and 1.5 million people in the United States have RA. The CDC also reports than mortality rates among RA patients are nearly 2.5 times higher than those in the general population, owing primarily to excess risk of cardiovascular disease, infections, and some cancers. The Medmeme report illustrates that treatment of these three indications commands much of the R&D effort and market in this therapeutic category and represents recent, notable scientific progress. R&D for the three indications also offers a window into issues that are relevant broadly across the category.

Medmeme CEO Mahesh Naithani describes the marketplace: ?The value of the immune/inflammatory disease pharmaceutical markets has been driven by very intense research to characterize pathological factors, which was then translated into development of highly targeted biological therapies. Commercial success has come to the companies and brands that have contributed to this clinical revolution. Just three drugs in this therapeutic area? Amgen/Pfizer?s Enbrel, Johnson & Johnson?s Remicade, and Abbott?s Humira? respectively were the seventh, eighth, and ninth highest selling pharmaceutical brands worldwide in 2010, with combined sales exceeding $ 18 billion. Need for new treatments and market potential have encouraged many companies to be active such as Roche, Merck, Biogen Idec, AstraZeneca, Eli Lilly, Novartis, Regeneron, GlaxoSmithKline, Astellas, and Sanofi, others too. Another major driver of success in immune/inflammatory disease markets has been company strategies of label expansion into multiple disease areas, particularly for biologics like the TNF-? inhibitors.?

Scientific data from the Medmeme database shows that discussion centering on late-stage RA emerging therapies in medical conference presentations and journal publications increased in 2011. This increase is primarily attributable to novel non-TNF-alpha target drugs such as: AstraZeneca?s fostamatinib, an oral Syk kinase inhibitor, Novartis?s secukinumab, a monoclonal antibody against IL-17A, and Pfizer?s tofacitinib, an oral JAK inhibitor. Of these three frontrunner emerging therapies, Pfizer?s tofacitinib may reach market this year. The drug was submitted for U.S. approval to treat RA at the end of 2011.

The syndicated TrendsmemeTM Report: Immune and Inflammatory Diseases can be purchased separately, or, along with other MedMeme reports in the new series, at discounted pricing. To learn more, contact us, or see our website, http://www.medmeme.com/products/syndicated-reports/reports/trendsmeme-reports.

Medmeme, LLC ????????????????????????????????????

Yan Barshay, Executive Vice President ????????????????

+1 212-725-5992???????????????????????????????????????? ????

yan(at)medmeme(dot)com????

????????????or

Ray Wright, Vice President, Sales

+ 1 508-278-4595

rwright(at)medmeme(dot)com







Find More Cardiovascular Disease Press Releases

Acne Most Common Skin Disease in the World Today

Birmingham (PRWEB) June 6, 2006

Acne is the most common skin disease in the world today. Acne is an inflammatory disease of the skin, caused by changes in the pilosebaceous units (skin structures consisting of a hair follicle and its associated sebaceous gland). It’s estimated that 90% of adolescents endure it, and that it occurs in up to 25% of all adults. The condition is common in puberty as a result of an abnormal response to normal levels of the male hormone testosterone. The response for most people diminishes over time and acne thus tends to disappear, or at least decrease, after one best acne treatment reaches their early twenties.

There is, however, no way to predict how long it will take for it to disappear entirely, and some individuals will continue to suffer from acne decades later, into their thirties and forties and even beyond. Despite these staggering statistics, acne treatment remains a mystery to many acne sufferers. This is partly due to social attitudes towards the condition and partly due to advertisements bombarding quick fix medication.

Acne treatment is available, it is a matter of being educated concerning the problem and choosing the correct approach to acne treatment. As with many conditions different people will have varying degrees of success with various treatments which is why its important stay informed of your options. Remember acne is not simply a skin condition, it is also the outward symptom of hormonal or other imbalance. The more you can do to address this, including dietary factors, exercise, topical treatments, and cleansing the better the results you will see. One of the most effective options can be found at http://acne-treatment-tips.blogspot.com.

If you are suffering from acne, it is important to know that acne treatment is available. Get the most effective treatment from http://acnemedicineforu.blogspot.com.

Acne is easily recognised by the appearance of spots and by their distribution on the body. Acne may cause you considerable emotional distress but there is a range of acne treatment options to help you tackle the problem.

No treatment will completely ‘cure’ your acne. The aims of acne treatment are to prevent new spots forming, to improve on acne treatment already present, and to prevent scarrings.

It is very important to learn as much information as possible about acne and acne treatment and to know what help and what treatments are available. There are many types of acne all with varying levels of severity. Cystic acne is one of the most severe forms of acne. It can be painful and it can also lead to troublesome scarring. As much as possible, it is best to seek acne treatment way before it ever reaches the level of cysts and nodules. However, if for some reason that has not been possible, aggressive acne treatment will be necessary to halt any further progression. Get you treatment that works at http://myproactiveacnetreatment.blogspot.com.

Although it is great to understand what is happening with your skin, for most people the most valuable information is how to solve the problem and where to get acne treatment that works. Most people simply want a cure, a cure that works. First, let us talk about what should not be done. Under no circumstances should a person struggling with cystic acne try to squeeze or burst a cyst. This can have detrimental consequences. Often, this will serve only to make any infection deeper, causing the cyst to take longer to heal than if left alone.

Unfortunately, no simple, catch-all cure exists for acne, especially severe acne. Most people find that they have to try several types of acne treatment or combinations of acne treatments before they are able to hit upon a solution. More often than not, it is a combination of various acne treatments that do the trick.

A very descriptive DVD on Facial Techniques for Treating Acne is also available at http://amazon–com.blogspot.com.

For more informatin, visit: http://acne–skin–care.blogspot.com.

###



Powered by WordPress | Designed by: best suv | Thanks to toyota suv, infiniti suv and lexus suv